SymBio Pharmaceuticals Limited [4582.T]
TOKYO, Apr 21 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) reported significant exercise of its 66th warrant shares during the period from April 1 to April 20, 2026. A total of 21,700 warrants were exercised out of 200,000 issued warrants, representing a ratio of 10.9%.
As of March 31, there were 200,000 unexercised warrants, which decreased to 178,300 by April 20. Key exercise activities included: - April 1: 50,000 shares delivered at an exercise price of ¥114,500 per share. - April 6: 300,000 shares delivered at an exercise price of ¥109,000 per share.
- April 14: 350,000 shares delivered at an exercise price of ¥98,000 per share. - April 16: 100,000 shares delivered at an exercise price of ¥97,000 per share. As of March 31, the outstanding share count was 72,238,910, including 91,169 treasury shares.
For more detailed information on the 66th warrant shares, refer to the July 22, 2025, announcement titled “Issuance of Third-Party Allocation Warrants (Exercise Price Adjustment Clause Attached) and Conclusion of Unsecured Ordinary Bond Purchase Agreement.”.
🟢 Confidence: High AI-translated content.